Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells

Journal of Pharmaceutical Sciences

Volumn 93, Issue 9, 2004, Pages 2205-2213

  Arnold, John J ^a   Ahsan, Fakhrul ^b   Meezan, Elias ^a   Pillion, Dennis J ^a  

^a University of Alabama at Birmingham   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Epoetin alfa; Insulin; Leptin; Nasal drug delivery; Somatropin; Transmission electron microscopy

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HUMAN GROWTH HORMONE; HUMAN INSULIN; PENETRATION ENHANCING AGENT; PEPTIDE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT LEPTIN; TETRADECYLMALTOSIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CELL STRUCTURE; CILIATED EPITHELIUM; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; EPITHELIUM CELL; INTERNALIZATION; INTRANASAL DRUG ADMINISTRATION; MALE; MAXIMUM PLASMA CONCENTRATION; MICROSCOPY; MOLECULAR WEIGHT; NONHUMAN; NOSE MUCOSA; PARAMETER; PINOCYTOSIS; RAT; TIME TO REACH PEAK CONCENTRATION; TRANSCYTOSIS;

EID: 4344705585     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20123     Document Type: Article

References (23)

1. Ugwoke MI, Verbeke N, Ringet R. 2001. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53:3-22.
2. Sayani AP, Chien YW. 1996. Systemic delivery of peptides and proteins across absorptive mucosae. Grit Rev Therap Drug Carrier Sys 13:85-184.
3. Edman P, Bjork E. 1992. Nasal delivery of peptide drugs. Adv Drug Deliv Rev 8:165-177.
4. Reed CJ. 1993. Drug metabolism in the nasal cavity: Relevance to toxicology. Drug Metab Rev 25:173-205.
5. Thornton-Manning JR, Dahl AR. 1997. Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes. Mutat Res 380:43-59.
6. McMartin C, Hutchinson LEF, Hyde R, Peters GE. 1987. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci 76:535-540.
7. Donovan MD, Huang Y. 1998. Large molecule particulate uptake in the nasal cavity: The effect of size on nasal absorption. Adv Drug Del Rev 29: 147-155.
8. Pillion DJ, Atchison JA, Gargiulo C, Wang RX, Wang P, Meezan E. 1994. Insulin delivery in nosedrops: New formulations containing alkylglycosides. Endocrinology 135:1386-1391.
9. Pillion DJ, Wang P, Yorks J, McCann P, Meezan E. 1995. Systemic absorption of insulin and glucagon applied to the eyes of rats and diabetic dogs. J Ocul Pharmacol 2:283-295.
10. Ahsan F, Arnold J, Meezan E, Pillion DJ. 2001. Enhanced bioavailibility of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats. Pharm Res 18:1742-1746.
11. Arnold J, Ahsan F, Meezan E, Pillion DJ. 2002. Nasal administration of low molecular weight heparin. J Pharm Sci 91:1707-1714.
12. Balzer D, Luders H. 2000. Nonionic surfactants: Alkyl polyglucosides. New York: Marcel Dekker. pp 1-12.
13. Liu D-Z, Lecluyse EL, Thakker DR. 1999. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. J Pharm Sci 88:1161-1168.
14. Uchiyama T, Sugiyama T, Quan YS, Kotani A, Okada N, Fujita T, Muranishi S, Yamamoto A. 1999. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: Their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. J Pharm Pharmacol 51:1241-1250.
15. Dimitrijevic D, Shaw A, Florence A. 2000. Effects of some non-ionic surfactants on transpithelial permeability in caco-2 cells. J Pharm Pharmacol 52: 157-162.
16. -). Eur J Pharm Sci 20:27-34.
17. Agerholm C, Bastholm L, Johansen PB, Nielsen MH, Elling F. 1994. Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-a- phosphatidylcholine and α-cyclodextrin in rabbits. J Pharm Sci 83:1706-1711.
18. Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R, Trail G, Lin FK, Browne JK, Hines DK. 1986. Characterization and biological effects of recombinant human erythropoietin. Immunobiol 172:213-224.
19. Monteiro-Riviere NA, Popp JA. 1984. Ultrastructural characterization of the nasal respiratory epithelium in the rat. Am J Anat 169:31-43.
20. Mygind N, Dahl R. 1998. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Del Rev 29:3-12.
21. Montiero-Riviere NA, Popp JA. 1986. Ultrastructural evaluation of acute toxicity in the rat respiratory epithelium in response to formaldehyde gas. Fund Appl Tox 6:251-262.
22. Sheetz MP, Dai J. 1996. Modulation of membrane dynamics and cell motility by membrane tension. Trends Cell Biol 6:85-89.
23. Heerklotz H. 2001. Membrane stress and permeabilization induced by asymmetric incorporation of compounds. Biophys J 81:184-195.